Alva Review-Courier -

By LINDA A. JOHNSON
AP Medical Writer 

FDA approves Lilly pill for common advanced breast cancer

 

September 29, 2017



U.S. regulators have approved a new medicine for treating a common type of breast cancer after it has spread to other parts of the body.

Eli Lilly's Verzenio was approved Thursday by the Food and Drug Administration for women and men with what's called HR-positive, HER2-negative breast cancer that has worsened after hormone therapy.

According to the FDA, about 72 percent of patients with breast cancer have this type.

The daily pill blocks certain enzymes that promote growth of cancer cells. It's to be used either alone, after hormone therapy and chemotherapy have stopped working, or in comb...



For access to this article please sign in or subscribe.

 

Reader Comments(0)

 
 

Our Family of Publications Includes:

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2021

Rendered 06/17/2021 17:54